152.42BMarket Cap
10.10P/E TTM
Novo Nordisk A/S's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Novo Nordisk A/S is 9.12, ranking 46 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 10.10, which is 400.48% below the recent high of 50.57 and 5.02% above the recent low of 9.60.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.